No abstract available
MeSH terms
-
Aged
-
Antineoplastic Agents / adverse effects*
-
Fusion Proteins, bcr-abl / antagonists & inhibitors
-
Fusion Proteins, bcr-abl / genetics
-
Humans
-
Imidazoles / adverse effects*
-
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / diagnosis
-
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy*
-
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / enzymology
-
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / genetics
-
Male
-
Molecular Targeted Therapy
-
Protein Kinase Inhibitors / adverse effects*
-
Pyridazines / adverse effects*
-
Remission Induction
-
Time Factors
-
Treatment Outcome
-
Watchful Waiting*
Substances
-
Antineoplastic Agents
-
BCR-ABL1 fusion protein, human
-
Imidazoles
-
Protein Kinase Inhibitors
-
Pyridazines
-
ponatinib
-
Fusion Proteins, bcr-abl